These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33483000)

  • 1. PET Assessment of Cardiac Allograft Vasculopathy.
    Chih S; Wiefels CC; Beanlands RSB
    Semin Nucl Med; 2021 Jul; 51(4):349-356. PubMed ID: 33483000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Myocardial Blood Flow for Post-transplant Surveillance and Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
    Feher A; Miller EJ
    Curr Cardiol Rep; 2022 Dec; 24(12):1865-1871. PubMed ID: 36279035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.
    Clerkin KJ; Topkara VK; Farr MA; Jain R; Colombo PC; Restaino S; Sayer G; Castillo M; Lam EY; Chernovolenko M; Yuzefpolskaya M; DeFilippis E; Latif F; Zorn E; Takeda K; Johnson LL; Uriel N; Einstein AJ
    J Am Coll Cardiol; 2022 Oct; 80(17):1617-1628. PubMed ID: 36265957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.
    Narang A; Blair JE; Patel MB; Mor-Avi V; Fedson SE; Uriel N; Lang RM; Patel AR
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1607-1617. PubMed ID: 29728952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation.
    Wiefels C; Almufleh A; Yao J; deKemp RA; Chong AY; Mielniczuk LM; Stadnick E; Davies RA; Beanlands RS; Chih S
    J Nucl Cardiol; 2022 Apr; 29(2):712-723. PubMed ID: 32918246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy.
    Miller CA; Sarma J; Naish JH; Yonan N; Williams SG; Shaw SM; Clark D; Pearce K; Stout M; Potluri R; Borg A; Coutts G; Chowdhary S; McCann GP; Parker GJ; Ray SG; Schmitt M
    J Am Coll Cardiol; 2014 Mar; 63(8):799-808. PubMed ID: 24355800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.
    Bravo PE; Bergmark BA; Vita T; Taqueti VR; Gupta A; Seidelmann S; Christensen TE; Osborne MT; Shah NR; Ghosh N; Hainer J; Bibbo CF; Harrington M; Costantino F; Mehra MR; Dorbala S; Blankstein R; Desai A; Stevenson L; Givertz MM; Di Carli MF
    Eur Heart J; 2018 Jan; 39(4):316-323. PubMed ID: 29236988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of multiparametric rubidium-82 PET myocardial blood flow quantification for cardiac allograft vasculopathy surveillance.
    Chih S; Chong AY; Bernick J; Wells GA; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Mielniczuk LM; Beanlands RSB
    J Nucl Cardiol; 2021 Oct; 28(5):2286-2298. PubMed ID: 31993956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Coronary Allograft Vasculopathy with Cardiac PET and Cardiac MRI.
    Madamanchi C; Konerman MC; Murthy VL
    Curr Cardiol Rep; 2021 Oct; 23(12):175. PubMed ID: 34657220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Real-Time Myocardial Contrast Echocardiography to Detect Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Fine NM; Greenway SC; Mulvagh SL; Huang R; Maxon SA; Hepinstall MJ; Anderson JH; Johnson JN
    J Am Soc Echocardiogr; 2021 May; 34(5):503-510. PubMed ID: 33359634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.
    Payne GA; Hage FG; Acharya D
    J Nucl Cardiol; 2016 Aug; 23(4):713-27. PubMed ID: 26711101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion Cardiac Magnetic Resonance Imaging as a Rule-Out Test for Cardiac Allograft Vasculopathy.
    Chih S; Ross HJ; Alba AC; Fan CS; Manlhiot C; Crean AM
    Am J Transplant; 2016 Oct; 16(10):3007-3015. PubMed ID: 27140676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive Detection of Cardiac Allograft Vasculopathy by Stress Exercise Echocardiographic Assessment of Myocardial Deformation.
    Clemmensen TS; Eiskjær H; Løgstrup BB; Tolbod LP; Harms HJ; Bouchelouche K; Hoff C; Frøkiær J; Poulsen SH
    J Am Soc Echocardiogr; 2016 May; 29(5):480-90. PubMed ID: 26898523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of heart transplant recipients with serial echocardiographic coronary flow reserve and dobutamine stress echocardiography to detect cardiac allograft vasculopathy.
    Sade LE; Eroğlu S; Yüce D; Bircan A; Pirat B; Sezgin A; Aydınalp A; Müderrisoğlu H
    J Am Soc Echocardiogr; 2014 May; 27(5):531-9. PubMed ID: 24613313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients.
    Nous FMA; Roest S; van Dijkman ED; Attrach M; Caliskan K; Brugts JJ; Nieman K; Hirsch A; Constantinescu AA; Manintveld OC; Budde RPJ
    Transpl Int; 2021 Oct; 34(10):1886-1894. PubMed ID: 34268796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation.
    Miller RJH; Manabe O; Tamarappoo B; Hayes S; Friedman JD; Slomka PJ; Patel J; Kobashigawa JA; Berman DS
    J Nucl Med; 2020 Feb; 61(2):249-255. PubMed ID: 31451490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.